References
- Sterner G, Nyman U. Contrast medium-induced nephropathy: aspects on incidence, consequences, risk factors, and prevention. Libyan J Med AOP:070402
- National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease:evaluation, classification, and stratification. Part 5. Evaluation of laboratory measurements for clinical assessment of kidney disease. Guideline 4. Estimation of GFR. Am J Kidney Dis 2002; 39:S76–110.
- Brosius FC et al. Circulation. 2006; 114:1083–1087.
- Nyman U, Almen T, Aspelin P, Hellstrom M, Kristiansson M, Sterner G. Contrast-medium-Induced nephropathy correlated to the ratio between dose in gram iodine and estimated GFR in ml/min. Acta Radiol 2005; 46:830–842.
- Chen M, Lekso L, Williams R. Measures of exposure versus measures of rate and extent of absorption. Clin Pharmacokinet 2001; 40:565–572.
- Sherwin PF, Cambron R, Johnson JA, Pierro JA. Contrast dose-to-creatinine clearance ratio as a potential indicator of risk for radiocontrast-induced nephropathy:correlation of D/CrCL with area under the contrast concentration-time curve using iodixanol. Invest Radiol 2005; 40:598–603.
- Laskey WK, Jenkins C, Selzer F, et al. NHLBI Dynamic Registry Investigators. Volume-to-creatinine clearance ratio:a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. J Am Coll Cardiol 2007; 50:584–590.